Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023Twirla First Quarter 2024 Demand..
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023Twirla First Quarter 2024 Demand..
https://www.genuinedrugs123.com/291-Anti-Cancer-Drugs-Generic-Ethinyl-Estradiol-Levonorgestrel-Brand-Altavera-Amethia.aspx
*PRINCETON, NJ / ACCESSWIRE / November 22, 2023 / Agile Therapeutics, Inc.* (NASDAQ:AGRX), the commercial-stage women's healthcare..